STOCK TITAN

Caribou Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Caribou Biosciences (Nasdaq: CRBU) said management will attend two investor conferences in February–March 2026. Key engagements include a fireside chat at the Citi 2026 Virtual Oncology Leadership Summit on Feb 19, 2026 at 10:45 AM ET and a fireside chat at the Leerink Global Healthcare Conference in Miami on Mar 10, 2026 at 8:00 AM ET.

A webcast of the Leerink presentation will be available via the company Events page and accessible for at least 30 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences:

  • Citi 2026 Virtual Oncology Leadership Summit, Virtual
    February 19, 2026, with a fireside chat at 10:45 AM ET
  • Leerink Global Healthcare Conference, Miami, FL
    March 10, 2026, with a fireside chat at 8:00 AM ET
    Webcast

For more information and link to the Leerink webcast, please visit the Events page on Caribou’s website. The webcast will be available on the Caribou website for at least 30 days after the event.

About Caribou Biosciences, Inc.
Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The Company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is focused on vispacabtagene regedleucel (vispa-cel) and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies. Follow the Company @CaribouBio and visit www.cariboubio.com.

Caribou Biosciences, Inc. contacts:
Peggy Vorwald, PhD
investor.relations@cariboubio.com
media@cariboubio.com


FAQ

When will Caribou Biosciences (CRBU) present at the Citi 2026 Virtual Oncology Leadership Summit?

Caribou will present on February 19, 2026 with a fireside chat at 10:45 AM ET. According to the company, the event is virtual and will feature management discussing the company's clinical-stage programs and strategy.

What time is the Caribou Biosciences (CRBU) fireside chat at the Leerink Global Healthcare Conference?

The fireside chat is scheduled for March 10, 2026 at 8:00 AM ET. According to the company, the session will take place in Miami and will be webcast for investors to view online.

Where can investors watch the Caribou Biosciences (CRBU) Leerink webcast and for how long will it be available?

Investors can watch the Leerink webcast on Caribou’s Events page on the company website. According to the company, the webcast will remain available for at least 30 days after the event.

Will Caribou Biosciences (CRBU) management discuss clinical programs during these 2026 investor conferences?

Yes—management will participate in fireside chats where clinical-stage programs are expected to be discussed. According to the company, the sessions aim to update investors on strategy and clinical progress.

How can investors find more details about Caribou Biosciences (CRBU) conference appearances in 2026?

Investors should visit the company Events page for schedules, webcast links, and replay access. According to the company, the Events page hosts links and additional information for each investor engagement.
Caribou Biosciences, Inc.

NASDAQ:CRBU

CRBU Rankings

CRBU Latest News

CRBU Latest SEC Filings

CRBU Stock Data

148.61M
83.60M
9.82%
42.39%
4.33%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BERKELEY